back insurance patient resources covid-19 response request records first visit info common clinical fees billing inquiries pay bill

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
Aurora
13123 East 16th Ave Aurora, CO 80045

720-777-1234

Scott Sagel, MD, PhD

Pediatric Pulmonology

Board Certified

Schedule Appointment

Locations

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
Aurora
13123 East 16th Ave Aurora, CO 80045

720-777-1234

Provider Expertise

Clinical Interest for Patients

My clinical and research interests include cystic fibrosis; primary ciliary dyskinesia; bronchiectasis; and nontuberculous mycobacteria infection.


Specialties

  • Pediatrics ( 1999 )
  • Pediatric Pulmonology ( 2002 , 2014 )

Conditions & Treatments

  • Lungs and Breathing

    Cystic Fibrosis, Lung Disease

Education & Training

Medical Schools

MD, Washington University in St. Louis School of Medicine (1996)


Undergraduate Schools

BA, University of Michigan (MI) (1992)


Graduate Schools

PhD, University of Colorado Denver (2010)


Internships

University of Colorado (Children's Hospital Colorado) Program (1997)


Residency Program

University of Colorado (Children's Hospital Colorado) Program (1999)


Fellowships

University of Colorado (Children's Hospital Colorado) Program (2002)

Professional Memberships

American Academy of Pediatrics (AAP), Member


American Thoracic Society (ATS), Member


Society For Pediatric Research (SPR), Member


Research & Grants

Research Interests for Patients

Dr. Sagel is a pediatrician who focuses on airway inflammation and lung disease in children with cystic fibrosis and primary ciliary dyskinesia. He serves as the director of the University of Colorado Cystic Fibrosis Center, as well as the lead site investigator for the National Institute of Health-funded Genetic Disorders of Mucociliary Clearance Consortium, a network dedicated to improving diagnostics and treatments for individuals with primary ciliary dyskinesia. Dr. Sagel’s research interests include: biomarkers of lung disease, including sputum and systemic markers of airway inflammation and injury; airway infections in cystic fibrosis including nontuberculous mycobacteria and the microbiome; and how bacterial pathogens relate to clinical outcomes in cystic fibrosis. Dr. Sagel’s research has been supported by the National Institutes of Health and the Cystic Fibrosis Foundation (CFF). An active member of the CFF, Dr. Sagel serves as co-chair of the CFF Biomarker Consortium and former chair of the Therapeutics Development Network Inflammatory Biomarkers Working Group. Dr. Sagel is Director of the NIH-funded University of Colorado Pediatric Clinical Translational Research Center Core Laboratory based at Children's Hospital Colorado and Director of the CFF-funded Center for Biochemical Markers.

information for referring providers

Referral Contact Phone

(720) 777-6181

Clinical Interests for Referring Providers

My clinical and research interests include cystic fibrosis; primary ciliary dyskinesia; bronchiectasis; and nontuberculous mycobacteria infection.